This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Dainippon Pharmaceutical Company, Limited. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: Seiji Iwama: Innovator in Medical Chemistry
Introduction
Seiji Iwama is a notable inventor based in Kishiwada, Japan. He has made significant contributions to the field of medical chemistry, particularly through his innovative patent work. His research focuses on compounds that have potential therapeutic applications.
Latest Patents
Seiji Iwama holds a patent for an aryl-substituted alicyclic compound and a medical composition comprising the same. The compound is characterized by a specific formula that includes various substituents, such as 1,4,5,6-tetrahydropyrimidin-2-yl and phenylene. This compound demonstrates high selectivity for αvβ3 integrin and exhibits potent inhibitory activity, making it useful as a preventive or therapeutic agent for diseases involving this integrin.
Career Highlights
Throughout his career, Seiji Iwama has worked with prominent companies in the pharmaceutical industry. He has been associated with Dainippon Pharmaceutical Company, Limited and Dainippon Sumitomo Pharma Co., Ltd. His work in these organizations has contributed to advancements in medical treatments and drug development.
Collaborations
Seiji Iwama has collaborated with notable colleagues, including Toshiya Morie and Mitsue Notake. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of their research.
Conclusion
Seiji Iwama's contributions to medical chemistry through his innovative patent work highlight his role as a significant inventor in the field. His research continues to pave the way for advancements in therapeutic agents.